IMU 0.00% 10.5¢ imugene limited

News: Imugene therapy targets cancer at Melbourne, Sydney Luncheons

  1. The “new” Imugene is involved in one of the hottest areas of cancer study and appears lightly valued V global peers in Immuno-Oncology...immunotherapy has become one of the most promising areas of study for the treatment of a variety of cancerous tumour. Charles Walker will present the new Imugene at the Melbourne (Tues 10th Feb) / Sydney Investor Luncheons (Wed 11th Feb).

 
watchlist Created with Sketch. Add IMU (ASX) to my watchlist
(20min delay)
Last
10.5¢
Change
0.000(0.00%)
Mkt cap ! $768.4M
Open High Low Value Volume
10.5¢ 10.8¢ 10.0¢ $746.7K 7.120M

Buyers (Bids)

No. Vol. Price($)
176 10004604 10.0¢
 

Sellers (Offers)

Price($) Vol. No.
10.5¢ 420568 8
View Market Depth
Last trade - 16.10pm 28/03/2024 (20 minute delay) ?
Last
10.3¢
  Change
0.000 ( 2.40 %)
Open High Low Volume
10.3¢ 10.5¢ 10.3¢ 1930285
Last updated 15.59pm 28/03/2024 ?
IMU (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.